Monica Shaw
Director/Board Member bij AC IMMUNE SA
Vermogen: 27 084 $ op 31-03-2024
Profiel
Monica Shaw is currently an Independent Non-Executive Director at AC Immune SA, a Senior Vice President-Major Markets at Bristol Myers Squibb Co., and the EVP-Head Region Europe, Canada & Australia at LEO Pharma.
A.
She is also a Member of The Royal College of Physicians and the VP-Commercial & Head-Asia Pacific Region at ViiV Healthcare Co. In the past, she was the Chief Executive Officer at Oncopeptides AB and the Medical Director & Chief Scientific Officer-UK at Novartis AG.
Dr. Shaw received a doctorate degree from Oxford University Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AC IMMUNE SA
0.01% | 01-03-2024 | 9 150 ( 0.01% ) | 27 084 $ | 31-03-2024 |
Actieve functies van Monica Shaw
| Bedrijven | Functie | Begin |
|---|---|---|
| AC IMMUNE SA | Director/Board Member | 29-10-2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 06-09-2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| ViiV Healthcare Co. | Corporate Officer/Principal | - |
Eerdere bekende functies van Monica Shaw
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOPEPTIDES AB | Chief Executive Officer | 07-08-2023 |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Chief Tech/Sci/R&D Officer | - |
Opleiding van Monica Shaw
| Oxford University Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AC IMMUNE SA | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
| ViiV Healthcare Co. |
